Acute colchicine intoxication during clarithromycin administration

Annals of Pharmacotherapy

Volumn 38, Issue 12, 2004, Pages 2074-2077

  Rollot, Florence ^a   Pajot, Olivier ^a   Chauvelot Moachon, Laurence ^a   Nazal, Eve M ^a   Kélaïdi, Charikleia ^a   Blanche, Philippe ^a  

^a Cochin Hospital ^*  (France)

Author keywords

Clarithromycin; Colchicine; P glycoprotein

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; COLCHICINE; OMEPRAZOLE; TRIACYLGLYCEROL LIPASE;

ABDOMINAL PAIN; AGED; ALOPECIA; ANAMNESIS; ARTICLE; CASE REPORT; DEHYDRATION; DIARRHEA; DOSE RESPONSE; FAMILIAL MEDITERRANEAN FEVER; FEVER; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; METABOLIC ACIDOSIS; PANCYTOPENIA; PRIORITY JOURNAL; SIDE EFFECT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VOMITING;

AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; COLCHICINE; DRUG INTERACTIONS; FAMILIAL MEDITERRANEAN FEVER; GASTRITIS; GOUT SUPPRESSANTS; HELICOBACTER PYLORI; HUMANS; MALE; OMEPRAZOLE;

EID: 12844259456     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E197     Document Type: Article

References (22)

1. Donovan JW. Non-steroidal anti-inflammatory drugs and colchicine. In: Haddad ML, Shannon MW, Winchester JF, eds. Clinical management of poisoning and drug overdose. 3rd ed. Philadelphia: WB Saunders, 1998:687-99.
2. Putterman C, Ben-Chetrit E, Caraco Y, Levy M. Colchicine intoxication: clinical pharmacology, risk factors, features, and management. Semin Arthritis Rheum 1991;21:143-55.
3. Tateishi T, Soucek P, Caraco Y, Guengerich P, Woods AJJ. Colchicine biotransformation by human liver microsomes. Identification of CYP3 A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol 1997;53:111-6.
4. Chappey O, Scherrmann JM. [Colchicine: recent data on pharmacokinetics and clinical pharmacology] French. Rev Med Interne 1995;16:782-800.
5. Wallace SL, Omokoku B, Ertel NH. Colchicine plasma levels: implications as to pharmacology and mechanism of action. Am J Med 1970;48:443-8.
6. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Delivery Rev 2003;55:3-29.
7. Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics. Clinical implications. Clin Pharmacokinet 2003;42:59-98.
8. Kim RB. Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab Rev 2002;34:47-54.
9. Gruberg L, Har-Zahav Y, Agranat O, Freimark D. Acute myopathy induced by colchicine in a cyclosporine treated transplant recipient: possible role of the multidrug resistance transporter. Transplantat Proc 1999;31:2157-8.
10. Pea F, Furlanut M. Pharmacokinetic aspects of treating infections in the intensive care unit. Focus on drug interactions. Clin Pharmacokinet 2001;40:833-68.
11. Wandel C, Kim RB, Kajiji S, Guengerich P, Wilkinson GR, Wood AJ. P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies. Cancer Res 1999;59:3944-8.
12. Wang L, Kitaichi K, Hui CS, Takagi K, Takagi K, Sakai M, et al. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. Clin Exp Pharmacol Physiol 2000;27:587-93.
13. Asakura E, Nakayama H, Sugie M, Zhao YL, Nadai M, Kitaichi K, et al. Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats. Eur J Pharmacol 2004;484:333-9.
14. Zapater P, Reus S, Tello A, Torrus D, Perez-Mateo M, Horga JF. A prospective study of the clarithromycin-digoxin interaction in elderly patients. J Antimicrob Chemother 2002;50:601-6.
15. Wakasugi H, Hano I, Ito T, Hashida T, Futami T, Nohara R, et al. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Clin Pharmacol Ther 1998;64:123-8.
16. Juurlink DN, Mamdani M, Kopp A, Laupalis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003;289:1652-8.
17. Tanaka H, Matsumoto K, Ueno K, Kodama M, Yoneda K, Katayama Y, et al. Effect of clarithromycin on steady-state digoxin concentrations. Ann Pharmacother 2003;37:178-81. DOI 10.1345/aph.1C203
18. Pauli-Magnus C, Rekersbrik S, Klotz U, Fromm MF. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein. Naunyn Schmiedebergs Arch Pharmacol 2001;364:551-7.
19. Caraco Y, Putterman C, Rahamimov R, Ben-Chetrit E. Acute colchicine intoxication - possible role of erythromycin administration. J Rheumatol 1992;19:494-6.
20. Dogukan A, Oymak FS, Taskapan H, Guven M, Tokgoz B, Utas C. Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration. Clin Nephrol 2001;55:181-2.
21. Borron SW, Scherrmann JM, Baud FJ. Markedly altered colchicine kinetics in a fatal intoxication: examination of contributing factors. Hum Exp Toxicol 1996;15:885-90.
22. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.